The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
iBio, Inc(NYSE MKT:IBIO) 
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scle...
Website: http://www.ibioinc.com
Founded: 2008
Full Time Employees: 43
Sector: Healthcare
Industry: Biotechnology
iBio Days Payable Outstanding ttm (DPO)
iBio Days Receivable Outstanding ttm (DSO)
iBio Days Inventory Outstanding ttm (DIO)
iBio Op Cashflow Per Share ttm
iBio Free Cashflow Per Share ttm
iBio Cash Per Share ttm
iBio P/S ratio ttm
iBio (GAAP) P/E ratio ttm
iBio P/B ratio ttm
No extra charts and metrics for this ticker.